Press Releases

 Filter by Provider

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of FMC Corporation (NYSE: FMC) between November 16, 2023 and February 4, 2025. FMC describes itself as an “agricultural sciences company which develops, markets, and sells crop protection chemicals including insecticides, herbicides, and fungicides.”

New York, New York--(Newsfile Corp. - April 3, 2025) - Digital Silk, an award-winning agency specializing in brand strategies, custom...

Homeowners across North America can now extend their swimming season with Covers in Play’s innovative automatic retractable pool enclosures. These state-of-the-art enclosures are designed to provide year-round pool access by offering seamless protection from harsh weather while maintaining the luxury of an open-air swimming experience.

Meet Bottom-Up Consulting, the Nova Scotia-based consulting firm that’s taking the leadership world by surprise with proven strategies for operational success.

This Marks One of the Most Competitive Podcast Auctions of the Year

NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP) $NRXP Set Up for $300 Million in Milestones on Tiered Double-Digit RoyaltiesMIAMI - April 3, 2025 - PRLog -- Term Sheet Signed for $2.5 Million Strategic Investment from a Global Medical Device Manufacturer into NRXP Subsidiary HOPE Therapeutics.Developing NRX-101, an FDA-Designated Investigational Breakthrough Therapy for Suicidal Treatment-Resistant Bipolar Depression and Chronic Pain.Aiming to be the First FDA-Approved Medication to Treat Suicidal DepressionDesigned to Help Address the Needs of Over 13 Million Americans who Seriously Consider Suicide Each Year (CDC).New Drug Application for Treatment of Suicidal Depression; Planned NDA for Accelerated Approval for Bipolar Depression in People at Risk of Akathisia.Binding Letter of Intent with Neurospa TMS Holdings, LLC for Expansion of its Planned International Network of Interventional Psychiatry Clinics.Accepted Non-Binding Potential Terms to License and Distribute NRX-100 Drug Providing Over $300 Million in Milestones Plus Tiered Double-Digit Royalties.Poised to Address Over $3 Billion Suicidal Depression Market in the US.Application to Uplist to NASDAQ Global Market from NASDAQ Capital MarketNRx Pharmaceuticals, Inc. (Stock Symbol: NRXP) is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain and PTSD. NRXP is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and chronic painNRXP has partnered with Alvogen Pharmaceuticals around the development and marketing of NRX-101 for the treatment of suicidal bipolar depression. NRX-101 additionally has potential to act as a non-opioid treatment for chronic pain, as well as a treatment for complicated UTI.NRXP is working on a New Drug Application for NRX-100 (IV ketamine) in the treatment of suicidal depression, based on results of well-controlled clinical trials conducted under the auspices of the US National Institutes of Health and newly obtained data from French health authorities, licensed under a data sharing agreement. NRXP was awarded Fast Track Designation for development of ketamine (NRX-100) by the US FDA as part of a protocol to treat patients with acute suicidality.Intravenous ketamine is widely accepted as a standard of care for acute treatment of suicidal depression, in the absence of an FDA-labeled product; the only treatment currently approved by the FDA is electroconvulsive therapy (ECT).  According to the CDC, 3.8 million Americans make a plan for suicide each year.  This represents a $3-5 billion market at expected pricing. Based on the data in the trials referenced above, the Company's regulatory counsel encouraged the Company to file an NDA for suicidal depression for NRX-100.In a January 2025 report, respected investment analysis firm D. Boral Capital assigned NRXP a $31 Price Target. The full report may be viewed at this link: https://www.nrxpharma.com/wp-content/uploads/2025/01/HOPE-Therapeutics-Advances-With-Kadima.pdf.Term Sheet for Strategic Investment from a Global Medical Device Manufacturer into NRXP Subsidiary HOPE TherapeuticsOn April 3rd NRXP announced signing of a term sheet with a global medical device manufacturer, as anticipated in the Company's recently filed annual report. The investor shares NRXP subsidiary HOPE's vision of providing comprehensive interventional psychiatry treatments to patients around the world. This Investment is intended to support initiation of HOPE's network of clinics to treat suicidal depression and PTSD with ketamine, TMS and other modalities.The Term Sheet, which is non-binding and subject to the execution of a definitive Stock Purchase Agreement, contemplates an investment of $2.5 million to purchase Series A Convertible Preferred Stock at a $50 million pre-money valuation. This investment, together with expected bank financing and current balance sheet assets, is anticipated to close concurrent with, and in support of, the closing of HOPE's recently announced clinic acquisitions.Binding Letter of Intent with Neurospa TMS Holdings, LLC for Expansion of its Planned International Network of Interventional Psychiatry ClinicsOn March 24th NRXP announced signing of a binding Letter of Intent to acquire a majority interest in Neurospa TMS Holdings, LLC. Neurospa operates six interventional psychiatry clinics on Florida's Gulf Coast and will constitute a key element of HOPE's Florida network going forward. Neurospa is revenue generating and EBITDA positive.Neurospa leverages state-of-the-art interventional psychiatry procedures, including Ketamine Infusion Therapy, Transcranial Magnetic Stimulation (TMS), and Spravato®, augmented by traditional psychiatry and talk therapy to provide a full continuum of care for people with depression, suicidality, PTSD, anxiety, and related disorders. TMS is an FDA-approved procedure in which focused electromagnetic treatment has been demonstrated to reduce symptoms of depression. Ketamine and Spravato® are similarly known to reduce symptoms of depression and both forms of treatment are increasingly used in an additive manner.Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate UpdateOn March 17th NRXP announced its financial results for the quarter and year ended December 31, 2024, and provided a business update.  The announcement included the following key highlights:NRXP initiated filing of a New Drug Application ("NDA") to the FDA for NRX-100 (IV Ketamine) for the treatment of Suicidal Depression; planned filing of an NDA for Accelerated Approval under Breakthrough Designation and Priority Review of NRX-101 for the treatment of bipolar depression in people at risk of akathisia. Both have anticipated PDUFA dates prior to December 31, 2025NRXP has accepted non-binding potential terms from a commercial pharmaceutical company to license and distribute NRX-100, providing over $300 million in milestones plus tiered double-digit royalties based on net salesNRXP retained a leading regulatory law firm to file a citizen's petition with the US Food and Drug Administration ("FDA") to remove benzethonium chloride – a toxic preservative -- from presentations of ketamine intended for intravenous use; planned 2Q25 filing of an Abbreviated New Drug Application ("ANDA") for the use of preservative-free ketamine in all current indicationsWholly owned subsidiary HOPE Therapeutics, signed non-binding letters of intent to acquire three precision psychiatry centers and is currently completing financial due diligence and definitive agreements. Currently negotiating the terms for the acquisition of six additional centersThe HOPE acquisitions are planned to form the foundation for a national network offering interventional psychiatry services to treat suicidal depression, post-traumatic stress disorder ("PTSD") and related conditionsNRXP received and negotiating a term sheet from a publicly-traded strategic investor currently engaged in manufacturing Transcranial Magnetic Stimulation ("TMS") devices to provide capital in support of expansion of further HOPE clinic acquisitions.NRXP has engaged BTIG as financial advisor for clinic acquisition and capital formation; leading global financial services firm specializing in investment banking, institutional trading, research, and related brokerage services for strategic growth opportunities.NRXP regained compliance with the NASDAQ market value of listed securities ("MVLS") requirement.Substantially reduced operating costs compared to prior yearManagement continues to forecast, although no assurances can be given, profitability on a forward-looking run-rate basis by year end 2025NRXP filed Module 3 (manufacturing) of its New Drug Application ("NDA") for NRX-100 (preservative-free sterile IV ketamine) in a tamper-resistant, diversion resistant packaging presentation in the fourth quarter of 2024. NRX-100 was previously granted Fast Track Designation by FDA in combination with use of NRX-101. Ketamine efficacy data from four clinical trials are intended to support the filing. Three manufacturing lots are now complete, with filed stability data suitable for shelf life exceeding two years at room temperature. The anticipated PDUFA date for this NDA is prior to December 31, 2025.NRX-100 is poised to address the over $3 billion Suicidal Depression market in the US.NRXP has accepted non-binding potential terms from a commercial pharmaceutical company to license and distribute NRX-100 (preservative-free IV ketamine) that provides for over $300 million in potential milestones plus a tiered double-digit royalty, subject to further due diligence and finalized agreement.NRXP estimates that the market for the initial indication is over $2 billion, while the broad bipolar market could exceed $5 billion.For more information on $NRXP visit: https://www.nrxpharma.com/ and https://compasslivemedia.com/case-study/nrx-pharmaceuticals/Media ContactCompany Name: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)Contact Person: Matthew Duffy, Chief Business OfficerCompany Website: https://www.nrxpharma.com/Email: mduffy@nrxpharma.comPhone: (484) 254-6134Home Country: United StatesDISCLAIMER: https://corporateads.com/disclaimer/Disclosure listed on the CorporateAds website

European Web3 investment leader DX Venture today announced the appointment of Malaysian tech investor DSJ (Dato' Sri Jason) as Global Executive Director, tasked with spearheading the firm’s Southeast Asia market expansion and AI strategy. This move solidifies Malaysia’s position as a “Web3-AI Super Hub” for DX Venture, aligning with the country’s ambitious digital economy blueprint.

WEST HARTFORD, Conn., April 03, 2025 (GLOBE NEWSWIRE) -- Legrand®, a global specialist in electrical and digital building infrastructures, announced its sixth consecutive global Corporate Social Responsibility (CSR) Roadmap, outlining aspirational goals for 2025-2027. Building on two decades of CSR progress, Legrand, North & Central America is driving positive change and reinforcing its commitment to a more sustainable and socially responsible future.

New York, NY () April 3, 2025 -- Silicon Valley expert Jeff Brown will host "The Robotaxi Emergency Briefing" on April 10 to discuss Tesla’s self-driving robotaxi fleet, set to launch in June, and its potential market impact.

While beauty and barber industries are experiencing continued growth; Vagaro, the leading software for businesses in beauty, wellness, and fitness, recently released their Vantage Report which explores this being driven by evolving trends, digital transformation, and shifting consumer behaviors.

Yesenia Scheker-Izquierdo Appointed U.S. Sector Leader for Asset Management and U.S. Line of Business Leader for Asset Management and Private...

RENO, NEVADA / ACCESS Newswire / April 3, 2025 / iWallet Corporation (IWAL) today announced it has reached a pivotal milestone in the development of its next-generation products, the iWallet 2.0 and iPassport, with final production prototypes slated for completion by the end of the second quarter of 2025. These products represent a significant leap forward in premium, security-focused accessories, tailored for the modern, mobile lifestyle.

From March 17 to 20, 2025, Mooe Robot showcased its collaborative intelligent handling solutions developed specifically for North American logistics scenarios at the ProMAT exhibition in the United States. With its three core advantages of "collaborative intelligence, individual intelligence, and human-machine collaboration," Mooe Robot successfully attracted industry attention, fully demonstrating its technological innovation capabilities and the global expansion potential of its efficient logistics solutions.

GA International, a global leader in laboratory identification solutions, under its LabTAG brand, announced today that its Dymo® LabelWriter™ 5-Series Printing Kits are now compatible with eLabNext’s Digital Lab Platform (DLP), an intuitive and flexible system for collecting, managing, and analyzing laboratory information. The integration is facilitated through an add-on, available in the eLabMarketplace, which provides researchers with a reliable, precise, and user-friendly solution for labeling in critical laboratory workflows.

Effective financial management is the backbone of every successful business. Whether you are an entrepreneur just starting out or a seasoned business owner, managing your finances strategically is central to decision-making, long-term growth, and overall success. With a track record of providing tailored tax planning and CFO services, Ronald A. Fossum offers solutions designed to meet your unique business challenges and propel your organization toward financial success.

Sheridan, Wyoming--(Newsfile Corp. - April 3, 2025) - IQ tests have long been recognized as a valuable tool for measuring...

The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed against AppLovin Corporation (“AppLovin”) (NASDAQ: APP) on behalf of those who purchased or otherwise acquired AppLovin securities between May 10, 2023, and February 25, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is May 5, 2025.

Shanghai, China - The highly anticipated '100% DORAEMON & FRIENDS' Tour has officially arrived in mainland China, launching at Shanghai's JingAn Kerry Centre (JAKC) on March 29. Organized by JAKC and AllRightsReserved (ARR) in collaboration with Fujiko Pro, this extraordinary exhibition brings the beloved world of Doraemon to fans in Shanghai, following its successful run in Hong Kong in 2024.

Reinforcing the company’s legacy and steadfast commitment to sustainability, Trex Company [NYSE:TREX], the world’s largest manufacturer of wood-alternative decking and residential railing, and leader in high-performance, low-maintenance outdoor living products, earned top honors in this year’s Environment + Energy (E+E) Leader Awards. Trex® composite decking was not only named Product of the Year but also the Judges’ Choice Winner as the top-scoring entry in the Consumer + Residential category.

The following is an excerpt from the new book Seducing Will Shakespeare by C.P. Campanello . Campanello is a Navy veteran based in Savannah, whose long time fascination with the Bard's poetry was the inspiration for this story.

New York, USA - April 3, 2025 - Aprofood, which leads the industry in food ingredients and additives, has launched its food preservation expert team to transform food safety and quality with new solutions. Through this initiative Aprofood demonstrates its strong commitment to delivering innovative products that meet modern consumer expectations in a dynamic market.

WEBTOON Entertainment Inc. (Nasdaq: WBTN), a leading global entertainment company and home to some of the world's largest storytelling platforms, is teaming up with The Ankler to talk about the growing influence of webcomics in culture and Hollywood at NAB Show 2025 in Las Vegas. WEBTOON Entertainment CFO & COO David J. Lee and Wattpad WEBTOON Studios Head of Global Entertainment David Madden will be joined by Natalie Jarvey, author of Ankler Media’s creator economy newsletter Like & Subscribe, who will moderate the conversation.

Maxim Crane Works, L.P. (“Maxim”) the nation’s leading provider of turn-key heavy lift solutions, is pleased to announce the acquisition of Tower Crane assets from a wholly owned subsidiary of Sims Crane & Equipment Co. (“Sims”), a prominent player in the Florida crane market. This strategic acquisition continues Maxim's efforts to refresh its fleet, expand its product offerings, enhance its market presence, and deliver even greater value to its customers.

Side Hustles Database, founded by internet entrepreneur Anthony Smith, is revolutionizing the way people approach financial independence by providing a comprehensive platform dedicated to side hustle opportunities. With a mission to help individuals from all walks of life take control of their financial future, the site offers a rich database of side hustle ideas, actionable advice, and first-hand entrepreneurial insights.

New York - On March 21, 2025, the "2025 Forbes China Industry Development Leaders Selection" opened in Shanghai, and Shanghai Yihang Network Technology Co., Ltd. (hereinafter referred to as "Yihang Technology") was awarded the title of "2025 Forbes China Leading Enterprise in Industry Development," showcasing its strong brand strength and market competitiveness.

CitizenShipper, the nation’s leading pet transport marketplace, has once again earned national attention — this time in a USA Today feature spotlighting what makes the service a standout choice for modern pet owners. As traditional air cargo transport continues to raise concerns among pet parents, CitizenShipper offers a refreshing alternative: one rooted in safety, compassion, and control.

Hyphen Solutions, the industry leader in residential construction software solutions, proudly exhibited at the International Builders’ Show (IBS) 2025 in Las Vegas, showcasing how "The Power of Connected Data" is transforming the industry.

After decades of development, Risen Energy has obtained great achievements and become the “Patent Moat”. Risen Energy, with its Global Photovoltaic Research Institute, has launched the Next-Gen Technology Revolution, which will greatly benefit the whole industry.

CLEVELAND, April 03, 2025 (GLOBE NEWSWIRE) -- Oatey Co., a leading manufacturer in the plumbing industry since 1916, announced today that Ron Carlson has joined the organization as Senior Vice President, U.S. Operations.

Las Vegas, NV - April 3, 2025 - American Dream Rally, an educational movement dedicated to empowering individuals with the knowledge to achieve financial independence, has launched its first-ever American Dream Rally, a one-day wealth-building experience designed to equip attendees with proven investment strategies. The inaugural event will take place in Dallas, Texas, on June 18, 2025, marking the beginning of a nationwide initiative aimed at helping Americans take control of their financial future.

AM Best has downgraded the Financial Strength Rating (FSR) to A- (Excellent) from A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) to “a-” (Excellent) from “a” (Excellent) of Mutual of America Life Insurance Company (MofA) (New York, NY). The outlook of these Credit Ratings (ratings) is negative. Concurrently, AM Best has downgraded the FSR to B++ (Good) from A- (Excellent) and the Long-Term ICRs to “bbb+” (Good) from “a-” (Excellent) of TruSpire Retirement Insurance Company (TruSpire) (Irving, TX), a wholly owned subsidiary of Mutual of America Life Insurance Company. The outlook of these ratings is stable.

Melville, NY - April 3, 2025 - Anne Napolitano Consulting, Inc., an all-women accounting and virtual CFO firm, is proud to announce the awarding of its first-ever Women in Accounting Scholarship to Alicia Vieau, a graduating high school senior from Michigan, in March 2025. This $1,000 scholarship reflects the firm’s commitment to empowering the next generation of female accounting professionals.

RAFTR Roofing + Exteriors (RAFTRx), a top-rated roofing and outdoor exterior solutions provider that specializes in the insurance-claim sector, announces today its acquisition of Kingdom Krafters. With its first presence in Missouri, RAFTRx continues its methodical growth of highly reputable, strategically located roofing and exterior companies that enhance its service capabilities and reinforce its commitment to improving communities one roof at a time.

Inszone Insurance Services, a rapidly growing national provider of commercial, personal, and benefits insurance solutions, is excited to announce its acquisition of Employee Benefits Advantage, a highly respected employee benefits agency located in Broken Arrow, Oklahoma.

Digital Displays that React, Adapt, and Deliver the Right Message, Right When It Matters Most

From March 29 to 30, the Innovating Hong Kong Global Talent Carnival 2025 (Spring) was held at the AsiaWorld Expo. The event attracted over 400 renowned enterprises from home and abroad, including Matrixport, Tencent, Huawei Hong Kong, Alibaba Cloud, Xiao Hong Shu, Keeta, and Bank of China (Hong Kong). The event aimed to connect job seekers with nearly 20,000 employment opportunities in blockchain, finance, Internet, technology, education and other industries.

Mentor Capital, Inc. (OTCQB: MNTR) reports that at this time, 100% of its Core Holdings that support its issued and outstanding Preferred Shares are backed by gold bullion set initially at today’s valuation of $100,928 per kilogram. The preferred gold holdings will not bear operating cost. The purpose is to allow accredited investors to immediately invest, and then move into suitable Mentor energy assets and projects selected by management at a normal pace. Upon selection, the energy asset, which will then begin to bear a ratio of associated costs, will be rotated into the Core Holdings and an equal value in gold will be rotated back to Mentor’s operations in a ledger transaction. Since initiated in June 2018, the Series Q Preferred Shares have delivered an average 11.03% compound annual rate of return for its accredited investors over that almost seven-year period. There is a 5% load added to exit by conversion into Mentor Common shares that can then be sold according to public market regulations. The changing common share conversion closing price is based on a date periodically specified by management, which is currently September 17, 2024. This calculates out to a conversion of preferred to common at 10.5 cents per common share.

CLEVELAND, April 03, 2025 (GLOBE NEWSWIRE) -- Oatey Co., a leading manufacturer in the plumbing industry since 1916, announced today that Jim Reginelli has joined the organization as Senior Vice President, Quality & Engineering.

London, United Kingdom - April 3, 2025 - Search Magic, a specialist SEO agency dedicated to the e-commerce sector, has successfully partnered with a U.S.-based online retailer, leading to a remarkable uplift in organic business performance. Through a comprehensive ecommerce SEO overhaul, the client doubled its daily pageviews and significantly boosted organic revenue within eight months.

What if we were able to talk about money the same way we discuss music?

Solaia Capital Advisors LLC, through its affiliates (collectively, “Solaia”) announce today the completion of an investment in Modjoul, Inc. (“Modjoul”), a leading provider of hardware, software, and AI solutions that enhance workplace safety and productivity for industrial companies. Modjoul’s effectiveness in reducing workplace injuries and costs has led to increased customer demand. Solaia’s investment provides Modjoul with the necessary capital to expand and diversify its customer base and to finalize the development and rollout of its latest AI Manager productivity offering.

Stephen Tanneberg of Tanneberg Company, LLC, is proud to announce the release of his new book “Fully Consecrated”, which offers a gripping narrative that takes readers through a personal journey of mental illnesses, treatment experiences and the transformative power of faith.

AM Best has revised the implications of the under review status to negative from developing for the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” (Excellent) of NASW Insurance Company (NASWIC) (Washington, D.C.).

Session to explore compliance, efficiency, and team collaboration in healthcare environments

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 first quarter financial results for Thursday, May 1, 2025, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.

FAYETTEVILLE, Ark. - April 3, 2025 - PRLog -- Lineus Medical has been granted five additional international patents for its flagship product, SafeBreak® Vascular, in Korea, Brazil, Australia, India, and China. These patents strengthen Lineus Medical's intellectual property portfolio as the company continues expanding into major healthcare markets worldwide. They also mark a key milestone toward obtaining regulatory clearances and establishing distribution partnerships in these regions.SafeBreak Vascular is the only break-away device for IV lines clinically proven to reduce IV complications1. When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patent's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money1."Securing these new patents is a critical step in advancing the global presence of SafeBreak," said Vance Clement, CEO of Lineus Medical. "They not only protect our product from being copied and add value to the company, they also provide us credibility in establishing relationships with new distribution partners in these countries."About Lineus Medical:Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications1. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Facebook, and Instagram.References:1.      Data on FilePhotos: (Click photo to enlarge) Source: Lineus MedicalRead Full Story - Lineus Medical Awarded Five Additional Patents | More news from this sourcePress release distribution by PRLog

The "USA Directory of Medical Devices & Diagnostics Companies 2025" has been added to ResearchAndMarkets.com's offering.

Today, Calix, Inc. (NYSE: CALX) recognizes local broadband experience providers (BXPs) for leveraging Calix SmartTown® and the Calix Broadband Platform to deliver critical connectivity to communities, subscribers, and first responders. Increasingly, Calix customers are transforming into BXPs—service providers that have grown and evolved beyond the basic utility mindset to meet every broadband need in their communities. By doing so, BXPs increase their ability to respond swiftly when natural disasters and emergencies occur. At the same time, they are proving that connectivity is not just about technology—it is about people, safety, and growing stronger, resilient communities.

Trusted Sydney Doctor Dr. Terry Nguyen Brings Accessible, Quality Medical Care to Sydney Homes with Nationwide Telehealth AccessSYDNEY - April 3, 2025 - PRLog -- After over a decade of treating thousands of patients across Australia, Dr. Terry Nguyen has launched HomeDoc, a premium medical service offering private house calls in Sydney and secure telehealth consultations Australia-wide. The service addresses a growing need for personalized medical care that functions outside conventional healthcare constraints.As primary care continues to be stretched to its limits each year, Dr. Nguyen identified a critical gap in patient care. Drawing from his dual qualifications in medicine and physiotherapy, he developed HomeDoc to restore the patient-doctor relationship to its fundamental purpose: caring for people in their own space, on their own terms."I wanted to bring medicine back to what it was meant to be," says Dr. Nguyen, Founder and Medical Director of HomeDoc. "Not just treating illness, but caring for people — with time to actually listen and understand their unique circumstances."HomeDoc offers:

The third distillery location brings premium spirits, tastings, and events to the heart of Whiskey Country.